Published On : 26 Jul 2016
QYResearchReports.com announces the addition of a new research report, titled “Global and China Coronary Stent Research Report to 2020.” The aging population is increasingly accepting minimally invasive surgeries and treatments. Advances in medical devices and the rising government funding has led to the launch of many new products and procedures in the healthcare sector. For instance, the introduction of drug-eluting stents, bioactive stents, bare metal, and radioactive stents is expected to increase the use of stents in treating coronary artery diseases. Additionally, the demand for stents such as biodegradable polymers, bifurcation stents, and bioabsorbable scaffolds is expected to increase globally. Advancements in stents will encourage a positive shift in treating coronary artery diseases, thereby propelling the global and China coronary stent market.
Attributes such as cost effectiveness, low risk, and short recovery time make these stents superior to traditional surgical procedures to cure coronary artery diseases. These are the primary findings of the report on the global and China coronary stent market, featured on QYResearchReports. By defining coronary stents, the report diverts its attention to study applications, classifications, and specifications of coronary stents.
The research, titled ‘Global and China Coronary Stent Research Report to 2020,’ further studies the comprehensive landscape of the markets by focusing on the industry chain structure, current market scenario, and its future developments. The report highlights the many benefits of using stents to treat coronary artery diseases. Stents are minimally invasive, which is why they are preferred over a bypass surgery to treat coronary artery diseases. Short recovery time and less discomfort are two of the attributes that make stents a preferred choice over a bypass surgery to treat coronary artery diseases.
To get sample copy of report visit @ https://www.qyresearchreports.com/sample/sample.php?rep_id=743187&type=E
For a detailed study, analysts have measured the demand for coronary stents across North America, Europe, Japan, Southeast Asia, China, and India. According to the report, the global and China coronary stent market is expected to exhibit a rapid growth during the period between 2015 and 2020. Product innovations and mergers between leading players and the new entrants will benefit the global and China coronary stent market, predict the analysts.
As per the findings of the study, the global and China coronary stent market is expected to benefit from the new generation stents that are in the development phase. Going forward, carbon-coated stents, platinum-coated steel stents, and antibody-coated stents are anticipated to contribute significantly towards the growth of the global and China coronary stent market. Manufacturers are consistently taking efforts to enhance their research and development activities to discover new stents for treating coronary diseases.
Some of the leading companies operating in the global and China coronary stent market are Medtronic, Abbott Vascular, Boston Scientific, Terumo, B Braun, Biosensors International, HEXACATH, Biotronik AG, ClearStream, Alvimedica, MicroPort, LEPU MEDICAL, SINOMED, Lifetech, LBC, and Essen Technology.
The introduction of new stents has made the global and China coronary stent market highly competitive. To maintain their dominance, leading players are focusing on strategic mergers and acquisitions with the new entrants. However, this also gives a chance to the new entrants to introduce their set of stents, making the market further competitive.